Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Monocyte Activation Test (MAT) Service

Introduction Mechanism Key Features Our Services Contact Us FAQs

Introduction

The Monocyte Activation Test (MAT) represents the most significant advancement in pyrogenicity testing since the 1970s. As the biopharmaceutical industry moves toward a post-rabbit era, MAT has emerged as the gold-standard in vitro method for ensuring that parenteral medicines, medical devices, and cell therapies are free from fever-inducing contaminants. MAT is specifically designed to replicate the human innate immune response, providing a scientifically superior predictive model for patient safety.

In 2026, the regulatory landscape reached a turning point: the European Pharmacopoeia officially suppressed the Rabbit Pyrogen Test (RPT), establishing MAT as the reference method for pyrogen detection. Creative Biolabs provides a high-sensitivity MAT service that bridges the gap between ethical animal-free testing and rigorous scientific data required for submissions.

The principle of Monocyte Activation Test (OA Literature)Fig.1 The biological principle of Monocyte Activation Test (MAT).1

Mechanism of Monocyte Activation Test (MAT)

The MAT functions by mimicking the human physiological fever response in a controlled laboratory environment. The mechanism centers on human monocytes which express a diverse array of pattern recognition receptors (PRRs) and most Toll-like receptors (TLRs).

Pyrogen Recognition

  • When exogenous pyrogens are incubated with human monocytes, these pyrogens bind to specific TLRs on the cell surface.

Activation Signaling

  • These binding trigger intracellular signaling pathways leading to the activation of the monocyte.

Cytokine Release

  • Once activated, the monocytes synthesize and secrete pro-inflammatory cytokines (e.g., IL-6, IL-1β).

Quantification

  • The amount of cytokine released is proportional to the pyrogenic potency, which can be converted into endotoxin equivalent units (EEU/mL).

Key Features of Monocyte Activation Test (MAT)

MAT is a human cell-based in vitro assay designed to detect the full spectrum of pyrogens in parenteral medicines and medical devices. Its key features center on its ability to mimic human physiology, ensuring a safety profile that traditional animal-based tests cannot provide.

Broad-Spectrum Detection

MAT detects the total pyrogens, including bacterial endotoxins and non-endotoxin pyrogens (NEPs).

High Sensitivity

Standard MAT services offer a limit of detection (LOD) as low as 0.05 EU/mL, even 0.001 EU/mL.

Overcoming Masking (LER)

MAT is robust against the low endotoxin recovery phenomenon.

Complex Matrix Compatibility

It is effective for testing products like human serum albumin, vaccines with aluminum adjuvants, and lipid-based parenterals.

Comparison of the MAT, RPT and LAL test

Feature RPT LAL Test MAT
Scientific Basis Rabbit physiological response Horseshoe crab hemolymph clotting Human immune system activation
Detected Pyrogens Endotoxin and NEP Gram-negative endotoxin Endotoxin and NEP
Relevance Limited (species differences) Low (non-mammalian) Highest (human-specific)
Ethical Status Animal intensive Horseshoe crabs Animal-free
Precision Qualitative Quantitative Quantitative

Our Monocyte Activation Test (MAT) Service

Creative Biolabs offers a suite of MAT services tailored to your specific product requirements. As the industry transitions away from animal-based models, our advanced platform offers a scientifically superior, human-relevant alternative for pyrogen detection in parenteral drugs, vaccines, and medical devices. Our MAT services are structured to ensure full compliance with Ph. Eur. 2.6.30 and USP <1225> standards, providing the critical data needed for global market approval.

  • MVD Calculation and Feasibility
    Calculate the Maximum Valid Dilution and perform spike-recovery tests with reference standard endotoxin.
  • Monocyte Preparation
    Utilize cryopreserved human PBMCs pooled from multiple donors or standardized Mono-Mac-6 cells.
  • Incubation and Stimulation
    Samples are incubated with monocytes. If pyrogens are present, the monocytes become activated and begin cytokine synthesis.
  • Cytokine Detection
    Harvest the cell culture supernatant and perform a high-sensitivity ELISA for IL-6 or IL-1β.
  • Data Analysis and EEU Conversion
    Using an endotoxin standard curve, convert the ELISA absorbance values into Endotoxin Equivalent units (EEU/mL).

Workflow of the Monocyte Activation Test (MAT) at Creative Biolabs

Contact Us

Creative Biolabs is your premier partner for Monocyte Activation Test (MAT) Services, offering scientifically superior and animal-free solutions for pyrogen detection. We provide the expertise and data packages necessary to ensure uncompromised patient safety and smooth regulatory approval in the modern biopharmaceutical landscape. Contact us for more information and to discuss your project.

FAQs

How does the MAT handle products that cause interference in LAL tests?

MAT is more robust than LAL because it uses a biological cell-based system rather than a simplified enzyme cascade. We utilize specific protocols or product-specific dilutions to abrogate interference from surfactants or proteins like albumin.

Is the MAT as sensitive as the LAL test?

Our MAT services typically reach a sensitivity of 0.05 EU/mL, which is well within the requirements for most parenteral products, and can be further optimized for high-sensitivity applications like dialysis fluids.

Why use IL-6 as a readout instead of other cytokines?

IL-6 is a stable, primary pro-inflammatory cytokine that provides a wide linear range for quantification. However, for products like HSA, we also offer IL-1β readouts, which can be even more representative of the rabbit-to-human fever correlation.

How do you ensure the human monocytes are consistent between tests?

We use standardized cell lines to eliminate donor-to-donor variability. We ensure every test is performed with ready-to-use and pre-qualified cells.

Reference

  1. Hasiwa, Nina, et al. "Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test." (2013). Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.14573/altex.2013.2.169
Contact Us
© 2026 Creative Biolabs. All rights reserved.